Trustbank Portfolio Analysis: Q2 2026 Investment Activity
This analysis details Trustbank's portfolio changes during the second quarter of 2026, highlighting significant additions and reductions.
As of June 30th, 2026, Trustbank's investment strategy for Q2 resulted in notable shifts across its portfolio. The bank's holdings saw a mix of increased allocations to established funds and ETFs, alongside the introduction of new positions.
Key Portfolio Changes During Q2 2026
The most significant activity involved substantial increases in shares for several existing holdings:
- Vanguard FTSE Developed Markets ETF (VEA) saw a major boost, with 40,749 additional shares purchased.
- iShares US Infrastructure ETF (IFRA) was significantly increased by acquiring an extra 14,333 shares.
- New positions were initiated with considerable share purchases:
- Innovator Growth 100 Power (NJUN) was added entirely new in this quarter.
- Innovator US Equity Power Buffer (PJUN) entered the portfolio completely fresh.
- Innovator International ETF (45783Y343) was added as a new position this quarter.
- Vanguard Total International Fund (BNDX) was completely newly allocated by the investor.
Focus on US Equities and Infrastructure
The bank demonstrated a continued focus on broad-based exposure through its holdings in large-cap index funds:
- Vanguard S&P 500 ETF (VOO) maintained its position with steady growth.
- SPDR S&P 500 ETF (SPY) also experienced slight share increases, reinforcing exposure to the US large-cap market.
Additionally, iShares Russell 1000 Growth ETF (IWF) showed a substantial increase in its allocation during this period. The bank also added new positions including the small-cap focused Innovator U.S. Small Cap Power ETF (KAPR).
Growth and Value Concentration
While maintaining allocations in established funds, Trustbank also added exposure to specific growth-oriented vehicles:
- JPMorgan Nasdaq Equity Premium ETF (JEPQ) was newly introduced.
The bank's interest in healthcare stocks remained strong, evidenced by the addition of Bristol Myers Squibb Co. (BMY) and continued investment in AbbVie Inc. (ABBV). Furthermore, the allocation to Innovator US Equity Power Buffer ETF (PNOV) increased significantly during this quarter.
No Disclosures for Certain Sectors
The data does not provide information on changes within the following sectors:
- Energy
- Communication Services
If Trustbank held positions in these sectors during Q2, no change activity was disclosed.